COM:BICYCLETHERAPEUTICS
Bicycle Therapeutics
- Stock
Last Close
20.26
22/11 21:00
Market Cap
895.71M
Beta: -
Volume Today
284.35K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 0.50 - | |||||||
average payables | 1.98M - | 1.92M 2.94% | 1.66M 13.61% | 2.04M 23.30% | 4.60M 124.99% | 9.76M 112.36% | ||
average receivables | 7.16M - | 9.23M 28.95% | 10.89M 17.99% | 13.27M 21.88% | 16.56M 24.77% | 22.62M 36.62% | ||
book value per share | -3.55 - | -5.25 47.99% | 8.44 260.64% | 4.99 40.91% | 13.82 177.10% | 9.13 33.92% | 10.42 14.16% | |
capex per share | -0.08 - | -0.09 6.56% | -0.14 57.80% | -0.06 55.48% | -0.08 29.24% | -0.64 690.30% | -0.08 87.14% | |
capex to depreciation | -3.35 - | -1.67 50.31% | -1.62 2.76% | -0.94 41.99% | -1.44 53.32% | -5.15 257.24% | -0.45 91.31% | |
capex to operating cash flow | 0.79 - | 0.05 94.22% | 0.05 19.50% | 0.07 24.13% | 0.14 103.41% | 0.22 60.69% | 0.05 78.09% | |
capex to revenue | -0.54 - | -0.17 69.24% | -0.11 32.21% | -0.12 2.51% | -0.17 50.26% | -1.31 656.44% | -0.11 91.73% | |
cash per share | 5.09 - | 4.77 6.33% | 8.34 74.92% | 7.10 14.83% | 17.50 146.44% | 11.43 34.67% | 14.79 29.35% | |
days of inventory on hand | ||||||||
days payables outstanding | ||||||||
days sales outstanding | 531.73 - | 578.65 8.82% | 188.97 67.34% | 514.06 172.04% | 371.65 27.70% | 535.20 44.01% | 325.26 39.23% | |
debt to assets | 0.04 - | 0.00 99.58% | 0.02 9,238.36% | 0.10 470.43% | 0.09 5.60% | 0.11 16.82% | 0.08 30.05% | |
debt to equity | -0.07 - | -0.00 99.69% | 0.02 9,545.19% | 0.17 714.45% | 0.13 22.51% | 0.16 27.84% | 0.12 25.96% | |
dividend yield | ||||||||
earnings yield | -0.10 - | -0.14 34.36% | -0.29 114.58% | -0.15 49.49% | -0.04 70.49% | -0.13 193.11% | -0.28 118.68% | |
enterprise value | 91.86M - | 96.14M 4.66% | 13.93M 85.51% | 223.45M 1,503.91% | 1.13B 406.22% | 583.13M 48.45% | 162.04M 72.21% | |
enterprise value over ebitda | -5.78 - | -4.57 20.98% | -0.53 88.41% | -4.36 722.62% | -17.27 296.31% | -5.26 69.55% | -0.96 81.74% | |
ev to operating cash flow | -64.92 - | -3.69 94.32% | -0.49 86.79% | -12.56 2,479.84% | -76.46 508.70% | -6.77 91.14% | -2.67 60.53% | |
ev to sales | 44.59 - | 13.47 69.79% | 1.01 92.51% | 21.51 2,030.47% | 96.71 349.65% | 40.32 58.31% | 6.01 85.10% | |
free cash flow per share | -0.19 - | -2.05 978.48% | -2.73 33.17% | -0.99 63.69% | -0.67 32.31% | -3.54 427.83% | -1.79 49.60% | |
free cash flow yield | -0.02 - | -0.17 978.48% | -0.29 69.47% | -0.06 80.92% | -0.01 80.04% | -0.12 985.44% | -0.10 17.49% | |
graham net net | -3.86 - | -5.99 55.23% | 7.29 221.70% | 4.24 41.74% | 12.53 195.23% | 7.26 42.10% | 8.99 23.91% | |
graham number | 9.88 - | 13.94 41.01% | 22.94 64.58% | 17.29 24.63% | 28.79 66.52% | 27.94 2.95% | 34.50 23.48% | |
income quality | 0.09 - | 1.19 1,271.64% | 0.93 21.69% | 0.35 62.69% | 0.22 36.51% | 0.76 245.05% | 0.34 56.07% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -113.70 - | -21.99 80.66% | -34.88 58.64% | -58.21 66.87% | ||||
interest debt per share | 0.25 - | 0.00 99.54% | 0.17 15,072.46% | 0.85 395.20% | 1.89 122.71% | 1.61 14.88% | 1.35 15.70% | |
inventory turnover | ||||||||
invested capital | -0.07 - | -0.00 99.69% | 0.02 9,545.19% | 0.17 714.45% | 0.13 22.51% | 0.16 27.84% | 0.12 25.96% | |
market cap | 159.52M - | 159.52M 0% | 104.16M 34.71% | 343.67M 229.95% | 1.53B 343.89% | 877.96M 42.45% | 643.51M 26.70% | |
net current asset value | -49.67M - | -74.68M 50.35% | 87.15M 216.69% | 90.03M 3.31% | 325.02M 261.01% | 229.56M 29.37% | 337.46M 47.00% | |
net debt to ebitda | 4.26 - | 3.01 29.28% | 3.43 13.86% | 2.34 31.66% | 6.02 156.81% | 2.66 55.84% | 2.85 7.28% | |
net income per share | -1.22 - | -1.64 34.36% | -2.77 68.62% | -2.66 3.86% | -2.67 0.07% | -3.80 42.53% | -5.08 33.57% | |
operating cash flow per share | -0.11 - | -1.96 1,742.97% | -2.59 32.05% | -0.93 64.13% | -0.59 36.47% | -2.90 391.82% | -1.70 41.33% | |
payables turnover | ||||||||
receivables turnover | 0.69 - | 0.63 8.11% | 1.93 206.22% | 0.71 63.24% | 0.98 38.32% | 0.68 30.56% | 1.12 64.54% | |
research and ddevelopement to revenue | 5.76 - | 2.91 49.49% | 1.85 36.39% | 3.19 72.40% | 3.84 20.26% | 5.64 47.06% | 5.80 2.81% | |
return on tangible assets | -0.22 - | -0.27 21.81% | -0.28 3.78% | -0.32 13.96% | -0.14 56.00% | -0.27 97.11% | -0.30 10.55% | |
revenue per share | 0.15 - | 0.54 246.41% | 1.25 132.76% | 0.54 56.57% | 0.47 13.99% | 0.49 4.48% | 0.76 55.43% | |
roe | 0.34 - | 0.31 9.21% | -0.33 204.97% | -0.53 62.71% | -0.19 63.89% | -0.42 115.71% | -0.49 17.01% | |
roic | 0.37 - | 0.31 16.99% | -0.27 187.91% | -0.46 69.32% | -0.16 65.29% | -0.35 121.25% | -0.45 27.30% | |
sales general and administrative to revenue | 3.11 - | 1.14 63.41% | 1.05 7.30% | 2.81 166.40% | 2.77 1.34% | 3.42 23.44% | 2.22 35.20% | |
shareholders equity per share | -3.55 - | -5.25 47.99% | 8.44 260.64% | 4.99 40.91% | 13.82 177.10% | 9.13 33.92% | 10.42 14.16% | |
stock based compensation to revenue | 0.25 - | 0.14 42.66% | 0.22 55.83% | 0.63 180.65% | 1.03 64.77% | 1.85 79.24% | 1.20 34.98% | |
tangible asset value | -47.18M - | -69.83M 47.99% | 93.20M 233.47% | 95.46M 2.43% | 346.25M 262.72% | 270.78M 21.80% | 370.93M 36.98% | |
tangible book value per share | -3.55 - | -5.25 47.99% | 8.44 260.64% | 4.99 40.91% | 13.82 177.10% | 9.13 33.92% | 10.42 14.16% | |
working capital | 62.06M - | 67.84M 9.31% | 95.33M 40.51% | 132.59M 39.10% | 422.32M 218.50% | 316.04M 25.16% | 492.33M 55.78% |
All numbers in USD (except ratios and percentages)